Company intelligence / Profile preview

Akron Operating Company

Boca Raton, Florida, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Akron Bio is a leading provider of critical materials and services for the cell and gene therapy industry. The company specializes in the manufacture of GMP-compliant ancillary materials, including cytokines, growth factors, media supplements, and specialized enzymes. By providing high-quality, regulatory-compliant raw materials, Akron Bio supports the development and commercialization of advanced therapies from discovery through clinical trials to large-scale production. Their offerings are designed to ensure the safety, purity, and consistency required for the production of life-saving regenerative medicines.

Modalities: Cell therapyGene therapyBiologicCytokineRecombinant protein
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Akron Operating Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akron Operating Company.

Explore the full profile